Home › Funds › BROOKTREE CAPITAL MANAGEMENT › JNJ

BROOKTREE CAPITAL MANAGEMENT position in JNJ

JOHNSON & JOHNSON · Health Care

BROOKTREE CAPITAL MANAGEMENT reported holding 15,044 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$4.0M, representing 2.75% of its reported portfolio and ranking #11 among its reported holdings. BROOKTREE CAPITAL MANAGEMENT has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)15.04K sh
Reported value held$3.98M
Portfolio Weight2.75%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BROOKTREE CAPITAL MANAGEMENT's JNJ position evolved

BROOKTREE CAPITAL MANAGEMENT first disclosed a stake in JNJ in Q3 2023 at 30,590 shares (US$4.8M). The position peaked in Q4 2025 at 29,879 shares, worth US$6.2M. Across 13 filings, BROOKTREE CAPITAL MANAGEMENT increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 15,044 shares valued at US$4.0M — an increase of 108 shares quarter over quarter.. Notable position changes include a 50% trim in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 30.59K $4.76M New
Q4 2023 29.76K $4.66M Reduce
Q1 2024 28.85K $4.56M Reduce
Q2 2024 27.27K $3.99M Reduce
Q3 2024 25.47K $4.13M Reduce
Q4 2024 25.89K $3.74M Add
Q1 2025 25.95K $4.30M Hold
Q2 2025 28.85K $4.41M Add
Q3 2025 30.23K $5.60M Add
Q4 2025 29.88K $6.18M Reduce
Q1 2026 14.90K $3.64M Reduce
Q2 2026 14.94K $3.79M Hold
Q3 2026 15.04K $3.98M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has BROOKTREE CAPITAL MANAGEMENT held JNJ?

BROOKTREE CAPITAL MANAGEMENT has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BROOKTREE CAPITAL MANAGEMENT's current position in JNJ?

As of Q3 2026, BROOKTREE CAPITAL MANAGEMENT holds 15.04K shares of JNJ (JOHNSON & JOHNSON), valued at $3.98M, representing 2.75% of its reported portfolio and ranking #11.

Has BROOKTREE CAPITAL MANAGEMENT been buying or selling JNJ?

In the latest 13F filing (Q3 2026), BROOKTREE CAPITAL MANAGEMENT increased its position in JNJ. The position peaked in Q4 2025 at 29.88K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.